DOTA-NI-FAPI-04

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

DOTA-NI-FAPI-04 is a FAP inhibitor (IC50 = 7.44 nM). DOTA-NI-FAPI-04 significantly enhances tumor uptake and retention capacity by integrating FAP targeting with a hypoxia-sensitive group (nitroimidazole). DOTA-NI-FAPI-04 chelates metal isotopes via DOTA to generate radioactive probes (such as [68Ga]Ga/DOTA-NI-FAPI-04 and [177Lu]Lu/DOTA-NI-FAPI-04), which can be used for cancer imaging and tumor diagnosis-related research.

For research use only. We do not sell to patients.

  • CAS No.: 3078291-78-5
  • Formula: C51H69F2N15O14
  • Molecular Weight:1154.18
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) DOTA-NI-FAPI-04

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00